Trial intelligence / Profile preview

Efficacy and Safety of Technetium Tc 99m Sulfur Colloid Injection for Tracing Sentinel Nodes in Breast Cancer

NCT07764653Phase 3Completed

Start
Jan 2024
Primary completion
Jun 2025
Countries
1
01

Overview

A Phase 3 trial of technetium tc 99m sulfur colloid in breast cancer. Started Jan 2024; status: completed.

02

Drugs

technetium tc 99m sulfur colloid
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT07764653.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07764653.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call